Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AntiBKV in BK virus infection in kidney transplant recipients
NCT05769582Phase 3Completed
- Sponsor
- Memo Therapeutics AG
- Start
- Apr 2023
- Primary completion
- Mar 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of potravitug in BK virus infection, sponsored by Memo Therapeutics AG. Started Apr 2023; status: completed.
02
Drugs
potravitug
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT05769582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05769582.